>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>Docosatrienoic Acid (cis-13,16,19-docosatrienoic acid)

Docosatrienoic Acid (cis-13,16,19-docosatrienoic acid) (Synonyms: cis-13,16,19-Docosatrienoic Acid)

Catalog No.GC32578

도코사트리엔산은 희귀한 &오메가-3 지방산입니다. Ki가 5 μ인 돼지 호중구 막에 대한 LTB4 결합을 억제합니다.

Products are for research use only. Not for human use. We do not sell to patients.

Docosatrienoic Acid (cis-13,16,19-docosatrienoic acid) Chemical Structure

Cas No.: 28845-86-5

Size 가격 재고 수량
5mg(149 mM*100μL in Ethanol)
US$54.00
재고 있음
10mg(149 mM*100μL in Ethanol)
US$81.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Docosatrienoic acid is a rare ω-3 fatty acid; inhibits LTB4 binding to pig neutrophil membranes with an Ki of 5 μM.

Docosatrienoic acid inhibits LTB4 binding to pig neutrophil membranes with an Ki of 5 μM[1].

Application of docosatrienic acid dose-dependently decreases the peak K+ current amplitide and accelerates the potassium activation and inactivation kinetics at all rat membrane potentials[2].

[1]. Yagaloff KA, et al. Essential fatty acids are antagonists of the leukotriene B4 receptor. Prostaglandins Leukot Essent Fatty Acids. 1995 May;52(5):293-7. [2]. Krutetskaia ZI, et al. The effect of docosatrienoic acid on the potassium channels of outward rectification in the membrane of rat peritoneal macrophages. Fiziol Zh Im I M Sechenova. 1995 Jul;81(7):111-9.

리뷰

Review for Docosatrienoic Acid (cis-13,16,19-docosatrienoic acid)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Docosatrienoic Acid (cis-13,16,19-docosatrienoic acid)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.